Home Prescribing pattern of antihypertensive medication and adherence to Joint National Commission-8 guidelines in a rural tertiary care Indian teaching hospital
Article
Licensed
Unlicensed Requires Authentication

Prescribing pattern of antihypertensive medication and adherence to Joint National Commission-8 guidelines in a rural tertiary care Indian teaching hospital

  • Rajesh Venkataraman ORCID logo , Muhammed Rashid ORCID logo EMAIL logo , Bhat Shashikantha ORCID logo , Ayyappankalathil Soumya ORCID logo , Greeshma Vijayan ORCID logo , Gloriya Grifth Manuel ORCID logo and Shahinur Islam ORCID logo
Published/Copyright: September 10, 2019

Abstract

Background

Antihypertensive medications are one among the most highly used drugs across the globe as well as in India, and their prescribing pattern will be erratic despite the various clinical guidelines. Few studies address the pattern and adherence to the standard treatment guidelines in India. This study aimed to review the prescribing pattern of antihypertensive medications in a rural tertiary care teaching Indian hospital and to investigate the adherence to the Joint National Commission-8 (JNC-8) guidelines on prevention, detection, evaluation, and treatment of hypertension in adults.

Methods

A prospective observational study was conducted among the participants from four different inpatient wards who are aged >18 years, without gender restriction. The prescription pattern was reviewed and adherence to the JNC-8 guidelines was also assessed. A purposive sampling technique was adopted and descriptive statistics were used in Statistical Package for the Social Sciences v16.

Results

Of the 101 participants included in the study, 62 (61.39%) were female, 23.76% were aged <30 and >60 years, and the other 52.48% belong to the range of 30–60 years. As per JNC-8 guidelines, 4.95%, 17.82%, 44.55%, and 32.67% of patients were classified as normal, pre-hypertensive, stage I, and stage II, respectively. Most of them (31.68%) were free from comorbidities. The most (23.76%) prescribed drug was calcium channel blocker (CCB), and 15.84% of the patients received combination therapy. Treatment was effective in 70.30% of the patients through analyzing their blood pressure even though the adherence to the JNC-8 guidelines was only in 54.46%.

Conclusions

Our study revealed that CCB was the most prescribed drug, and in spite of the only 50% adherence rate, treatment was effective in the majority of the population. The treatment outcome can be improved if the adherence rate is increased further.

Acknowledgments

The participants and their caretakers are highly acknowledged for their time and support for this study.

  1. Author contributions: Rashid M, Venkataraman R, Shashikantha, Soumya A, Vijayan G, and Islam S contributed to study conception and design; Rashid M, Soumya A, and Vijayan G contributed to data acquisition, data analysis and interpretation, and writing of the article; Rashid M, Shashikantha, Venkataraman R, Soumya A, Vijayan G, Manuel GG, and Islam S contributed to editing, reviewing, revising, and final approval of the article. All authors have accepted responsibility for the entire content of the submitted manuscript and approved the submission.

  2. Research funding: No funding was received from any organization or funders.

  3. Competing interests: The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

  4. Informed consent: A written undersigned informed consent was obtained from all the participants after explaining the study procedures and right of patients in English or in common language (Kannada) whenever necessary.

  5. Ethical approval: All study procedures were carried out according to the Declaration of Helsinki, and the study was approved by institutional ethical committee (AIMS/IEC/1342/2018-19). An experienced consultant physician and practicing clinical pharmacists were directly involved in conducting the study.

References

[1] Magyar K, Gal R, Riba A, Habon T, Halmosi R, Toth K. From hypertension to heart failure. World J Hypertens 2015;5:85–92.10.5494/wjh.v5.i2.85Search in Google Scholar

[2] Gupta R, Xavier D. Hypertension: the most important non communicable disease risk factor in India. Indian Heart J 2018;70:565–72.10.1016/j.ihj.2018.02.003Search in Google Scholar PubMed PubMed Central

[3] Abel N, Contino K, Jain N, Grewal N, Grand E, Hagans I, et al. Eighth Joint National Committee (JNC-8) guidelines and the outpatient management of hypertension in the African-American population. N Am J Med Sci 2015;7:438–45.10.4103/1947-2714.168669Search in Google Scholar PubMed PubMed Central

[4] Kelly RK, Magnussen CG. Epidemiology of elevated blood pressure in youth and its utility for predicting adulthood outcomes: a review. World J Hypertens 2014;4:29–36.10.5494/wjh.v4.i4.29Search in Google Scholar

[5] Mankadavath A, Chandrasekhar D, Thomas T, Zuhra F, Kaipanthodi S, Parambil CJ. A prospective drug use evaluation of antihypertensive drugs in in-patients of a tertiary referral care hospital. Basic Clin Physiol Pharmacol 2015;26:295–300.10.1515/jbcpp-2013-0131Search in Google Scholar PubMed

[6] Mahajan R. Joint National Committee 8 report: how it differs from JNC 7. Int J Appl Basic Med Res 2014;4:61–2.10.4103/2229-516X.136773Search in Google Scholar PubMed PubMed Central

[7] Hernandez-Vila E. A review of the JNC 8 blood pressure guideline. Tex Heart Inst J 2015;42:226–8.10.14503/THIJ-15-5067Search in Google Scholar PubMed PubMed Central

[8] Thinda N, Tringali S, Huang J. Blood pressure goals: a moving target. World J Hypertens 2018;8:1–4.10.5494/wjh.v8.i1.1Search in Google Scholar

[9] Jarari N, Rao N, Peela JR, Ellafi KA, Shakila S, Said AR, et al. A review on prescribing patterns of antihypertensive drugs. BMC 2016;Article no. 7.10.1186/s40885-016-0042-0Search in Google Scholar PubMed PubMed Central

[10] Walley T, Duggan AK, Haycox AR, Niziol CJ. Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK. J R Soc Med 2003;96:525–31.10.1177/014107680309601104Search in Google Scholar

[11] Gillis EE, Sullivan JC. Sex differences in hypertension: recent advances. Hypertension 2016;68:1322–7.10.1161/HYPERTENSIONAHA.116.06602Search in Google Scholar PubMed PubMed Central

[12] Augustine DX, Coates-Bradshaw LD, Willis J, Harkness A, Ring L, Grapsa J, et al. Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography. Echo Res Pract 2018;5:G11–24.10.1530/ERP-17-0071Search in Google Scholar PubMed PubMed Central

[13] Shah AJ, Singh V, Patil SP, Gadkari MR, Ramchandani V, Doshi KJ. Factors affecting compliance to antihypertensive treatment among adults in a tertiary care hospital in Mumbai. Indian J Commun Med 2018;43:53–5.10.4103/ijcm.IJCM_40_17Search in Google Scholar PubMed PubMed Central

[14] Magadza C, Radloff SE, Srinivas SC. The effect of an educational intervention on patients’ knowledge about hypertension, beliefs about medicines, and adherence. Res Social Admin Pharm 2009;5:363–75.10.1016/j.sapharm.2009.01.004Search in Google Scholar PubMed

[15] Sharma A, Badwal TK, Gupta V, Rathore MS, Chhabra M, Gaur A. Drug utilization study on hypertensive patients and assessment of medication adherence to JNC-8 guidelines in North Indian tertiary care hospital: a cross-sectional study. J Sci Res Adv 2018. doi: 10.19080/ARGH.2018.09.555751.Search in Google Scholar

[16] Singh Juhi, Tyagi Shubham Singh, Jangra Manjeet Singh, Rashid Muhammed, Chhabra Manik, Tripathi Raman Kumar. Ataxia, Manifestation of Phenytoin Toxicity: A Case Report. J Young Pharm. 2019;11(1):112–113.10.5530/jyp.2019.11.24Search in Google Scholar

[17] Muhammed Rashid Parambil P, Juny S, Madhan R, Narayanappa D, Sathya Narayana P. Gingival Overgrowth on Chronic use of Amlodipine: A Case Report. Indian Journal of Pharmacy Practice. 2017;10(4):298–301.10.5530/ijopp.10.4.61Search in Google Scholar

[18] Muhammed R, Ananth K, Krishna U. Valproic acid and Stevens‐Johnson syndrome: a systematic review of descriptive studies. Int J Dermatol. 2019;58(9):1014–1022.10.1111/ijd.14411Search in Google Scholar PubMed

Received: 2019-05-29
Accepted: 2019-07-12
Published Online: 2019-09-10

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Minireview
  2. Pharmacokinetics and pharmacodynamics of mitragynine, the principle alkaloid of Mitragyna speciosa: present knowledge and future directions in perspective of pain
  3. Original Articles
  4. Trehalose protects against spinal cord injury through regulating heat shock proteins 27 and 70 and caspase-3 genes expression
  5. Evaluation of cytogenotoxic potential of Morinda lucida leaf extract on Swiss albino male mice using two bioassays
  6. Acute and subacute toxicity evaluation of calcium carbide and ethylene glycol in Wistar albino rats
  7. Evaluation of the possible hepatotoxic and nephrotoxic potentials of the Averrhoa carambola juice extract in female albino rats
  8. Chlorpyrifos and its metabolite modulates angiogenesis in the chorioallantoic membrane of chick embryo
  9. Prescribing pattern of antihypertensive medication and adherence to Joint National Commission-8 guidelines in a rural tertiary care Indian teaching hospital
  10. Assessment of cardiac risk in chronic asymptomatic alcoholics using blood pressure and electrocardiogram, and the relation with duration of drinking
  11. Effect of ghrelin on VEGF-B and connexin-43 in a rat model of doxorubicin-induced cardiomyopathy
  12. In vitro antioxidant and enzyme inhibitory properties of the n-butanol fraction of Senna podocarpa (Guill. and Perr.) leaf
  13. Blood pressure-reducing activity of Gongronema latifolium Benth. (Apocynaeceae) and the identification of its main phytochemicals by UHPLC Q-Orbitrap mass spectrometry
  14. Evaluation of the anticonvulsant and anxiolytic-like activities of aqueous leaf extract of Cymbopogon citratus in mice
  15. Terpenoids and phytosteroids isolated from Commelina benghalensis Linn. with antioxidant activity
  16. Miscellaneous
  17. Suspected reactivation of extrapulmonary tuberculosis focus after non-medical abuse of anabolic androgenic steroids: a case report
  18. Acknowledgment
Downloaded on 6.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2019-0133/html
Scroll to top button